HOTH earnings: next report 2026-09-02, real EPS beat/miss history, analyst consensus Buy, P/E -1.04. Updated 2026-07-23.
Hoth Therapeutics (HOTH) Research Hub
Hoth Therapeutics (HOTH) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-07-22, shares last closed at 0.8271 USD (-2.04%), in a range — moving averages not aligned / flat. Valuation: trailing P/E -1.04, market cap 0.01B. This hub links to the full technical, earnings and options research available for HOTH.
Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.8271 USD (-2.04%) |
| 52-week range | 0.4894 USD – 2.45 USD |
| Trend regime | Range |
| 14-day RSI | 40.6 (Bearish) |
| Trailing P/E | -1.04 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for HOTH
Covered Call on HOTH: how it works, illustrative setup around the real 0.8256 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HOTH: how it works, illustrative setup around the real 0.8256 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HOTH: how it works, illustrative setup around the real 0.8256 USD price, max profit/loss, breakeven and when to use it. Educational.
HOTH technical analysis: range, last 0.8271 USD, RSI 40.6, 52w range 0.4894 USD–2.45 USD, real support/resistance. Updated 2026-07-22.
Frequently asked questions
What sector is HOTH in?
Hoth Therapeutics (HOTH) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HOTH in an uptrend or downtrend?
As of 2026-07-22, HOTH is in a range — moving averages not aligned / flat. See the full technical research page for support and resistance levels.
What is HOTH's trailing P/E ratio?
HOTH's trailing P/E is -1.04, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does HOTH next report earnings?
HOTH is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of -0.1424 USD.